Tus kws kho mob
QP43-21 MHCP Pharmacy Benefit Exclusion for Jemperli and Zynlonta™
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 26, 2021
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1571 - 1580 ntawm 4374
Tus kws kho mob
QP44-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Zeposia® (ozanimod)
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 26, 2021
Tus kws kho mob
2021 June Provider Press
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 25, 2021
Tus kws kho mob
BlueRide Incident Report Form
Tus kws kho mob
QP41-21 Commercial and MHCP Pharmacy Benefit Exclusion for Qutenza®
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 12, 2021
Tus kws kho mob
QP40-21 Commercial Pharmacy Benefit Update – New and Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective July 1, 2021
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 12, 2021
Tus kws kho mob
QP42-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Hemophilia Agents
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 12, 2021
Tus kws kho mob
QP2-21 Update for New to Market Medical Drugs: Aducanumab, Casimersen, Evinacumab, Idecabtagene Vicleucel, and Pegunigalsidase Alfa
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 13, 2021
Tus kws kho mob
Transportation Services Level of Need